Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Kushner

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Clinical Pharmacology and Therapeutics|March 1, 1979
Long-term antiarrhythmic therapy with N-acetylprocainamideJ J Lertora, A J Atkinson, W Kushner, et al.
Annals of Internal Medicine|May 1, 1979
Remission of procainamide-induced lupus erythematosus with N-acetylprocainamide therapyG P Stec, J J Lertora, A J Atkinson, et al.
Journal of the American College of Cardiology|September 1, 1984
Torsade de pointes induced by N-acetylprocainamideM J Chow, A A Piergies, D J Bowsher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 6, 2025
Genomic landscape of clinically acquired resistance alterations in patients treated with KRAS<sup>G12C</sup> inhibitorsJ M Riedl, F Fece de la Cruz, J J Lin, et al.
Cancer Discovery|January 8, 2026
Acquired on-target alterations drive clinical resistance to p53-Y220C reactivatorsFerran Fece de la Cruz, Andreas Varkaris, Parasvi S Patel, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Clinical Pharmacology and Therapeutics|March 1, 1979
Long-term antiarrhythmic therapy with N-acetylprocainamideJ J Lertora, A J Atkinson, W Kushner, et al.
Annals of Internal Medicine|May 1, 1979
Remission of procainamide-induced lupus erythematosus with N-acetylprocainamide therapyG P Stec, J J Lertora, A J Atkinson, et al.
Journal of the American College of Cardiology|September 1, 1984
Torsade de pointes induced by N-acetylprocainamideM J Chow, A A Piergies, D J Bowsher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 6, 2025
Genomic landscape of clinically acquired resistance alterations in patients treated with KRAS<sup>G12C</sup> inhibitorsJ M Riedl, F Fece de la Cruz, J J Lin, et al.
Cancer Discovery|January 8, 2026
Acquired on-target alterations drive clinical resistance to p53-Y220C reactivatorsFerran Fece de la Cruz, Andreas Varkaris, Parasvi S Patel, et al.
Pageof 2